Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2003
12/24/2003CN1462626A Health products for improving functions of stomach intestine
12/24/2003CN1462625A ÔÇÿLingmaÔÇÖ Chinese herbal medicine wine
12/24/2003CN1131862C 经吡咯烷基、哌啶基或高哌啶基取代的(苯并二噁烷,苯并呋喃或苯并吡喃)衍生物 After pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/24/2003CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression
12/24/2003CA2489470A1 Prodrug and process for producing the same
12/24/2003CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
12/24/2003CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003CA2489361A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003CA2489315A1 Formulation of nefopam and its use in the treatment of pain
12/24/2003CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids
12/24/2003CA2489306A1 Use of nefopam for the treatment of nausea or emesis
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/24/2003CA2488880A1 Quinone-based therapeutic agent for hepatopathy
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003CA2488699A1 Indole, indazole, and benzazole derivative
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003CA2487111A1 Mammalian animal composition
12/24/2003CA2485346A1 Human adam-10 inhibitors
12/23/2003US6667341 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters; anticancer agents, hemological disorders, and inherited metabolic disorders
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667324 Dry blend pharmaceutical formulations
12/23/2003US6667323 Dry-blend pharmaceutical formulations
12/23/2003US6667321 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667309 Such as 3-benzyl-2-cyclopenten-1-one; for treatment of gastrointestinal disorders such as irritable bowel syndrome or esophageal reflux, and inhibiting side effects with administration of erythromycin
12/23/2003US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003US6667033 Administering daily effective dose of interferon-beta in two portions for four weeks
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003WO2003104473A2 Galactosyl isomalt, method for production and use thereof
12/18/2003WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104268A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104196A1 Non-peptidic brs-3 agonists
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103705A1 Metalloproteinase inhibitors
12/18/2003WO2003103698A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/18/2003WO2003103691A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103682A1 Compositions for cancer therapy saponins or sapogenins
12/18/2003WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003103640A1 Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103581A2 Compositions and methods for liver growth and liver protection
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003082857A3 Lansoprazole polymorphs and processes for preparation thereof
12/18/2003WO2003082817A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2003068246A3 Improvements in or relating to compositions
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003051306A3 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
12/18/2003WO2003040726A3 Screening for hepatitis c virus entry inhibitors
12/18/2003WO2003039677A3 Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003028712A3 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003022804A9 Method for the preparation of crystalline tetrahydrobenzothiepines
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals
12/18/2003WO2002074157A3 A mammalian immortalized liver cell
12/18/2003WO2002058723A3 Chemokines as adjuvants of immune response
12/18/2003WO2002047716A3 Chronic treatment regimen using glucagon-like insulinotropic peptides
12/18/2003WO2002042443A3 Use of modulators of eukaryotic signal transduction pathways for the treatment of helicobacter infections
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
1 ... 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 ... 1258